State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia

Publisher： Karger

E-ISSN： 2296-5262|39|1-2|25-32

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.39, Iss.1-2, 2016-0, pp. : 25-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 9, 2016-08 ,pp. : 525-533

Karger

Access to resources Recommend Favorite

Ofatumumab for the treatment of chronic lymphocytic leukemia

By Robak Tadeusz  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 577-587

Future Medicine

Access to resources Recommend Favorite

New oral small molecules in the treatment of chronic lymphocytic leukemia

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1917-1926

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : 446-460

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathogenesis, Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Exciting Times

By  

Oncology Research and Treatment, Vol. 39, Iss. 1-2, 2016-0 ,pp. : 8-8

Karger

Access to resources Recommend Favorite